COMMUNIQUÉS West-GlobeNewswire

FDA Selects Kyowa Kirin for PreCheck Pilot Program to Accelerate Manufacturing Timelines and Enhance Supply Chain Resilience
30/06/2026
Strategic collaboration at Sanford, North Carolina facility, currently under construction, to optimize cGMP validation, accelerate time-to-market for complex biologics, and shore up U.S. medicine supply TOKYO and [...]
Nelipak Healthcare Packaging receives ISCC PLUS certification for Clara, Ireland production facility
30/06/2026
ISCC certification reflects Nelipak’s commitment to supporting customers with innovative and sustainable packaging solutions CRANSTON, R.I., June 30, 2026 (GLOBE NEWSWIRE) -- Nelipak Corporation (“Nelipak”), a leading [...]
Applied Biologics Announces National Commercial Expansion to Support Continued Growth of XWRAP® and Future Biologic Product Pipeline
30/06/2026
SCOTTSDALE, Ariz., June 30, 2026 (GLOBE NEWSWIRE) -- Applied Biologics today announced the expansion of its national commercial organization as the Company continues to support growing demand for XWRAP® while preparing [...]
Psychemedics Releases 2026 Education Insights Report
30/06/2026
New Report Examines Emerging Student Substance Use Trends and Their Impact on Academic Success, Student Wellness, and Campus Safety DALLAS, June 30, 2026 (GLOBE NEWSWIRE) -- Psychemedics Corporation, the pioneer and [...]
Exicure Announces Board and Committee Changes
30/06/2026
WILMINGTON, Del., June 30, 2026 (GLOBE NEWSWIRE) -- Exicure, Inc. (Nasdaq: XCUR) ("Exicure" or the "Company") today announced changes to its Board of Directors and Board committees following actions approved by the [...]
Vivos’ Vida® Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study Participants
30/06/2026
LITTLETON, Colo., June 30, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS) , a leading medical device and healthcare services company focused on the treatment of breathing‑ [...]
Arizona Nonprofit Launches "Second Chance" Fundraiser for Custom Lexus LX 700h Overtrail to Benefit Childhood Blindness Research
30/06/2026
Limited-time campaign gives supporters one final opportunity to win a custom luxury SUV while helping fund clinical trials for inherited retinal diseases. GILBERT, Ariz., June 30, 2026 (GLOBE NEWSWIRE) -- A Race Against [...]
Serenity Medical Receives U.S. FDA Breakthrough Device Designation for The Serenity Shepherd Stent™ System to Treat Pulsatile Tinnitus
30/06/2026
Second FDA Regulatory Milestone for Serenity’s Novel Platform, Following the Recent HDE Approval of the River Stent™ – First Venous Stent for Severe, Refractory Idiopathic Intracranial Hypertension (IIH) HARRISON, N.Y [...]
Artelo Biosciences Presents Evidence for a Common Lipid-Signaling Link Across Multiple Potential Indications for Its FABP5 Inhibitor Platform at ICRS 2026
30/06/2026
Multi-omics analyses identifies linoleic acid as a critical fatty acid which is modulated by ART26.12 SOLANA BEACH, Calif., June 30, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage [...]
Arcutis Launches New Virtual Health Platform Supporting Access to Care for Individuals Living with Chronic Inflammatory Skin Diseases, Including Approved ZORYVE® (roflumilast) Indications
30/06/2026
Virtual health platform offers an additional pathway to care for the more than 45 million people in the U.S. living with eczema, seborrheic dermatitis, and plaque psoriasis Connects eligible individuals with independent [...]
Dogwood Therapeutics Appoints Iain Dukes, Venture Partner at OrbiMed, as Chair of Scientific Advisory Board
30/06/2026
Veteran Biopharma Executive and Venture Investor to Lead Newly Formed Dogwood Advisory Board in advance of Halneuron® Phase 2b Data Which is Projected for Fall of 2026 ALPHARETTA, Ga., June 30, 2026 (GLOBE NEWSWIRE) -- [...]
Sharecare teams up with AWS to deliver health navigation through agentic, multi-model AI with AskMD
30/06/2026
AskMD orchestrates multiple foundation models through a single governed layer to deliver secure, scalable, insurance-aware health guidance tailored to the individual ATLANTA, June 30, 2026 (GLOBE NEWSWIRE) -- Sharecare [...]
TPN.health Introduces Proprietary Integrated Claims and Credentialing Platform: Resolves Patient Barriers to Behavioral Health Access and Ensures Clinician Payments
30/06/2026
NEW ORLEANS, June 30, 2026 (GLOBE NEWSWIRE) -- TPN.health , the operating system for behavioral health, highlights the value of the first-of-its-kind integrated claims and credentialing platform that connects provider [...]
Adam Ferrari Health Science Scholarship Closes 2026 Application Window
30/06/2026
The Ferrari Foundation Begins Finalist Review for Its $20,000 Award, with a Recipient to Be Named September 1, 2026 IRVINE, Calif., June 30, 2026 (GLOBE NEWSWIRE) -- The Ferrari Foundation has closed the 2026 [...]
SS Innovations Named Outstanding Company Winner at the 2026 Surgical Robotics Industry Awards
30/06/2026
Company celebrated for advancing global access to its innovative robotic surgery platform FORT LAUDERDALE, Fla., June 30, 2026 (GLOBE NEWSWIRE) -- via IBN -- SS Innovations International, Inc. (the “Company” or “SS [...]
Trinity Biotech’s Trinovium Secures Open Compute Project Membership, Advancing Hyperscale Market Access and Commercial Validation for AI Data Center Liquid Cooling
30/06/2026
- Milestone an important step in launching Trinovium within the global AI data center ecosystem - Data center liquid cooling market projected to expand from $4 billion in 2026 to $27 billion by 2033 1 DUBLIN and [...]
SCYNEXIS Initiates Phase 1 Study of SCY-770, a Novel AMPK Activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
30/06/2026
Dose-optimization data from the Phase 1 study expected Q3 2026 to support Phase 2 proof-of-concept initiation in ADPKD in Q4 2026 JERSEY CITY, N.J., June 30, 2026 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX ), a [...]
Allarity Therapeutics Announces the Grant of Essential U.S. Patent for Its Stenoparib DRP® Companion Diagnostic
30/06/2026
Key U.S. patent now protects exclusivity for developing stenoparib with the stenoparib-DRP ® until April 2042 TARPON SPRINGS, Fla., June 30, 2026 – Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR [...]
MediciNova CEO Provides Shareholder Update
30/06/2026
LA JOLLA, Calif., June 30, 2026 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875 [...]

Pages